Although chemotherapy is always clinically administered in the context of a tumor, our goal in this preclinical study was to specifically understand the interaction of ACVR2B/Fc with the cachexia-inducing mechanisms driven by chemotherapy. The gene discussed is ACVR2B; the disease is neoplasm.